文献
J-GLOBAL ID:201702267821800242
整理番号:17A1962314
超高齢者,不適当な急性骨髄性白血病患者における低用量レナリドミド+シタラビン:第II相試験の最終結果【Powered by NICT】
Low-dose lenalidomide plus cytarabine in very elderly, unfit acute myeloid leukemia patients: Final result of a phase II study
著者 (13件):
Visani Giuseppe
(Hematology and Hematopoietic Stem Cell Transplant Center, AORMN, Pesaro, Italy)
,
Ferrara Felicetto
(Hematology, Cardarelli Hospital, Napoli, Italy)
,
Di Raimondo Francesco
(Hematology, Catania University, Catania, Italy)
,
Loscocco Federica
(Hematology and Hematopoietic Stem Cell Transplant Center, AORMN, Pesaro, Italy)
,
Fuligni Fabio
(Department of Experimental, Diagnostic, and Specialty Medicine, S. Orsola-Malpighi Hospital, University School of Medicine, Bologna, Italy)
,
Paolini Stefania
(Department of Experimental, Diagnostic, and Specialty Medicine, S. Orsola-Malpighi Hospital, University School of Medicine, Bologna, Italy)
,
Zammit Valentina
(Hematology, Catania University, Catania, Italy)
,
Spina Eleonora
(Hematology, Catania University, Catania, Italy)
,
Rocchi Marco
(Institute of Biomathematics, Urbino University, Urbino, Italy)
,
Visani Axel
(Department of Experimental, Diagnostic, and Specialty Medicine, S. Orsola-Malpighi Hospital, University School of Medicine, Bologna, Italy)
,
Piccaluga Pier Paolo
(Department of Experimental, Diagnostic, and Specialty Medicine, S. Orsola-Malpighi Hospital, University School of Medicine, Bologna, Italy)
,
Piccaluga Pier Paolo
(Section of Genomics and Personalized Medicine, Euro-Mediterranean Institute of Science and Technology (IEMEST), Palermo, Italy)
,
Isidori Alessandro
(Hematology and Hematopoietic Stem Cell Transplant Center, AORMN, Pesaro, Italy)
資料名:
Leukemia Research
(Leukemia Research)
巻:
62
ページ:
77-83
発行年:
2017年
JST資料番号:
T0017A
ISSN:
0145-2126
CODEN:
LEREDD
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)